2021
DOI: 10.1016/j.yrtph.2020.104855
|View full text |Cite
|
Sign up to set email alerts
|

Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 55 publications
(94 reference statements)
0
8
0
Order By: Relevance
“…In some cases, the component is explicitly mentioned, with the authors clearly describing the component in a specific assessment context, including giving detailed explanations through examples. For example, Pestana et al ( 2021 ) explicitly mention “no observed adverse effect level (NOAEL)” for determining the risk of triazoles from oral 90-day studies in rats as the assessment endpoint. In other cases, the components are implicitly mentioned through a description in a general context without, for example, providing examples that explain it.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In some cases, the component is explicitly mentioned, with the authors clearly describing the component in a specific assessment context, including giving detailed explanations through examples. For example, Pestana et al ( 2021 ) explicitly mention “no observed adverse effect level (NOAEL)” for determining the risk of triazoles from oral 90-day studies in rats as the assessment endpoint. In other cases, the components are implicitly mentioned through a description in a general context without, for example, providing examples that explain it.…”
Section: Resultsmentioning
confidence: 99%
“…The US Environmental Protection Agency (US EPA) also recently launched a plan to develop a scientific confidence framework to evaluate the quality, reliability, and relevance of non-animal testing approaches, including in silico methods for regulatory chemical risk assessment (US EPA 2021 ). While considerable attention has been paid to identifying sources of uncertainty relatable to the various phases of model construction and application (Ball et al 2014 ; Blackburn and Stuard 2014 ; Cronin et al 2019a , b ; Escher et al 2019 ; Johnson et al 2022 ; Patlewicz et al 2015 ; Pestana et al 2021 ; Pham et al 2019 ; Rathman et al 2018 ; Schultz et al 2015 , 2019 ; Viceconti et al 2021 ), comparatively little focus has been dedicated towards addressing uncertainty liable to arise during problem formulation (PF).…”
Section: Introductionmentioning
confidence: 99%
“…There are clear demands and opportunities for incorporating New Approach Methodologies (NAMs) into chemical safety assessment across multiple sectors ( ECHA, 2016 ; Knight et al, 2021 ; Lanzoni et al, 2019 ; Pistollato et al, 2021 ). Considerable progress has already been made to demonstrate how NAMs can be used in various contexts including read-across ( Escher et al, 2019 ; Pestana et al, 2021 ), Integrated Approaches to Testing and Assessment (IATA) ( OECD, 2020 ) and Next Generation Risk Assessment (NGRA) ( Baltazar et al, 2020 ; Berggren et al, 2017 ). Recently too, it has been shown how in vitro bioactivity data generated with high-throughput screening assays can be used to derive a PoD to serve screening-level human health safety assessments ( Paul Friedman et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Work is already underway at the EU-ToxRisk project and elsewhere to incorporate NAMs data for readacross based on ECHA's Read Across Assessment Framework (RAAF), (ECHA, 2015), (Escher et al, 2019;Mahony et al, 2020, Rovida et al, 2020Rovida et al, 2021). In one example based on ECHA's RAAF, data from NAMs was used to reduce the uncertainty for a read-across assignment for a group of triazole compounds (Pestana et al, 2021).…”
Section: Read-acrossmentioning
confidence: 99%